Fish & Richardson Names Biosimilars Litigator As New CEO

Law360 (February 22, 2020, 12:04 AM EST) -- Fish & Richardson PC principals have voted for John C. Adkisson to take over as the president and CEO of the nation's largest intellectual property firm, but that doesn’t mean he’s about to give up his biosimilar-focused patent litigation practice.

Adkisson on Thursday took over at the firm where he’s spent almost all of his career, which has featured big victories against companies like Janssen and AbbVie. And while he has his eye on big-picture issues like bulking up the firm’s international presence, the Minneapolis-based lawyer said he doesn’t want to lose touch with the more day-to-day aspects of being a practicing...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!